[News Brief] Fangzhou Launches Once-Weekly Diabetes Combination Therapy in China
Fangzhou Inc. has launched Novo Nordisk’s Kyinsu® on its Internet hospital platform in China, making the once-weekly basal insulin and GLP-1 receptor agonist combination therapy available through its AI-enabled chronic…
[News Brief] OTR Therapeutics and LG Chem Partner to Advance Oncology Assets
OTR Therapeutics and LG Chem have entered into a strategic framework agreement to identify, evaluate and develop novel oncology assets originating from China’s biopharmaceutical sector. This summary is based on…
[News Brief] Tanabe Divests Manufacturing Unit to Towa Pharmaceutical
Tanabe Pharmaceutical has agreed to sell its domestic manufacturing subsidiary, Tanabe Pharma Factory, to Towa Pharmaceutical as part of a strategic shift towards research, development and business development. This summary…
[News Brief] Lotus Pharma Commences South Korean Distribution of Uro-Vaxom
Lotus Pharmaceutical has announced that its subsidiary, Alvogen Korea, has commenced distribution of Uro-Vaxom in South Korea following an agreement with OM Pharma. This summary is based on a news…
[News Brief] REPROCELL Seeks Japan Approval for Stem Cell Therapy
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative medicine product intended to treat spinocerebellar ataxia. This summary is based on a news…
[News Brief] Sanyou Bio and Baiyunshan Xihe Partner on Radiopharmaceutical Development
Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have signed a strategic collaboration agreement to co-develop radiopharmaceutical and radiodiagnostic products by combining their expertise in artificial intelligence-driven drug discovery and…
[News Brief] Mahidol University Partners with WE-WIN on Pharmaceutical Research
Mahidol University’s Faculty of Pharmacy and Taiwan’s WE-WIN Bio-Medical Co., Ltd. have signed a memorandum of understanding to strengthen collaboration in pharmaceutical research, natural products and academic exchange between Thailand…
[News Brief] DKSH Partners with Lilly in Hong Kong and Macau
DKSH Business Unit Healthcare has entered into a distribution and promotion agreement with Eli Lilly Export S.A. to sell, promote and distribute Lilly’s pharmaceutical portfolio in Hong Kong and Macau,…
[News Brief] CanSinoBIO Receives Argentine Approval for Meningococcal Vaccine
CanSino Biologics Inc. has received a drug registration certificate from Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) for its ACYW135 Meningococcal Polysaccharide Conjugate Vaccine, Menhycia. This summary…
[News Brief] Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine
Anixa Biosciences has announced that the Korean Ministry of Intellectual Property has granted a composition-of-matter patent for its breast cancer vaccine technology. This summary is based on a news report…
[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeC
[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeC NeuroSense Therapeutics has reported biomarker findings from its Phase 2 RoAD proof-of-concept study evaluating PrimeC in patients with Alzheimer’s disease.…
[News Brief] Nippon Shinyaku Signs Option Agreement with Elixirgen
Nippon Shinyaku has entered into an option agreement with Elixirgen Therapeutics under which it may obtain exclusive worldwide rights to develop and commercialise EXG-7001 for the treatment of Duchenne muscular…
[News Brief] Zydus Lifesciences and Sunshine Healthcare Form Sri Lanka Joint Venture
Zydus Lifesciences and Sunshine Healthcare have announced a joint venture to establish a pharmaceutical manufacturing facility in Sri Lanka. This summary is based on a news report published by BioSpectrum…
[News Brief] Chime Biologics Expands Manufacturing Capacity with Cytiva Partnership
Chime Biologics has inaugurated its GMP-2 manufacturing facility in Wuhan, China, as part of its ongoing collaboration with life sciences company Cytiva to expand biologics manufacturing capacity. This summary is…
[News Brief] SK Biopharmaceuticals Collaborates with Insilico Medicine for AI Drug Discovery
SK Biopharmaceuticals and Insilico Medicine have entered a research and development collaboration to discover drug candidates for neuroimmune disorders of the central nervous system. This summary is based on a…
[News Brief] SystImmune and Biokin Secure China Approval for Iza-bren
SystImmune and Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren (BL-B01D1) to treat recurrent or metastatic nasopharyngeal carcinoma in patients whose disease progressed after platinum-based chemotherapy and…
[News Brief] Axcelead DDP Joins Eli Lilly TuneLab Collaboration
Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, an artificial intelligence and machine learning drug discovery platform developed by Eli Lilly and Company. This summary…
[News Brief] Haisco Pharma and Eli Lilly Sign Research Collaboration
China-based Haisco Pharmaceutical Group has entered a licensing and research collaboration with Eli Lilly and Company to discover and develop innovative medicines across multiple therapeutic areas. This summary is based…
[News Brief] Daewoong Pharma Partners for Dupilumab Biosimilar Development
South Korea-based Daewoong Pharmaceutical has partnered with China-based Chime Biologics to develop and manufacture a dupilumab biosimilar candidate referencing Dupixent. This summary is based on a news article published by…
[News Brief] PharmaEssentia Receives Taiwan Approval for Besremi in ET
PharmaEssentia Corporation has received approval from Taiwan’s Ministry of Health and Welfare for Besremi (ropeginterferon alfa-2b) for the treatment of adult patients with essential thrombocythemia (ET). This summary is based…
[News Brief] Formosa Pharma Signs Licensing Deal With Samil Pharmaceutical
Formosa Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with Samil Pharmaceutical Co., Ltd. for the commercialisation of an ophthalmic drug in Vietnam. This summary is based on a…
[News Brief] Mabwell Completes Dual Listing on Hong Kong Stock Exchange
Mabwell has completed a dual primary listing on the Main Board of the Hong Kong Stock Exchange following its earlier listing on the Shanghai Stock Exchange STAR Market, marking an…
[News Brief] LongBio Pharma Lists on Hong Kong Stock Exchange
LongBio Pharma has listed its shares on the Main Board of the Hong Kong Stock Exchange following its initial public offering, marking its entry into public markets as a biopharmaceutical…
[News Brief] Hanmi Pharma Partners with Organon for Southeast Asia
Hanmi Pharmaceutical has entered into a supply agreement with Organon to export three combination medicines for the Malaysian and Philippine markets as part of the companies’ expansion efforts in Southeast…
[News Brief] Lundbeck Receives South Korean Authorisation for Vyepti
H. Lundbeck A/S has received marketing authorisation from South Korea’s Ministry of Food and Drug Safety (MFDS) for Vyepti (eptinezumab) as a preventive treatment for migraine in adults. This summary…
[News Brief] Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
Samsung Bioepis, a South Korea-based company, has launched its ustekinumab biosimilar in Japan through its partnership with Nipro Corporation, expanding access to biologic treatments for immune-mediated conditions. This summary is…
[News Brief] Hyundai Bioscience Prepares Antiviral Supply for Outbreaks
South Korea-based Hyundai Bioscience has announced its readiness to supply its broad-spectrum antiviral drug XAFTY® in the event of Ebola or hantavirus outbreaks, subject to government or international request. This…
[News Brief] Lotus Pharmaceutical Acquires UTI Product Rights in South Korea
Lotus Pharmaceutical, a Taiwan-based company, has entered into an agreement with OM Pharma to acquire the assets of a specialty biopharmaceutical product for the prevention of recurrent urinary tract infections…
[News Brief] China Formalises Drug Trial Data Protection Measures
China’s National Medical Products Administration (NMPA) has issued new implementation measures formalising protection for eligible undisclosed drug trial data submitted in marketing authorisation applications in China. This summary is based…
[News Brief] Ribo and Insilico Medicine Form AI-siRNA Collaboration
Suzhou Ribo Life Science Co., Ltd. and Insilico Medicine have entered into a strategic collaboration to integrate artificial intelligence platforms into small interfering RNA (siRNA) drug development across discovery and…
[News Brief] Nuance Pharma Secures IND Approval for Actair® Trial
Nuance Pharma has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration to begin a Phase III clinical trial of its house dust mite allergy immunotherapy tablet,…
[News Brief] HKSAR Government Promotes Health Innovation in Switzerland
The Secretary for Health of Hong Kong SAR, Professor Lo Chung-mau, met multinational pharmaceutical and healthcare companies in Zurich, Switzerland to present policy measures aimed at strengthening Hong Kong’s drug…
[News Brief] KM Biologics and Serum Institute of India Enters Vaccine Collaboration
KM Biologics, a group company of Meiji Seika Pharma, has entered into a technology collaboration with Serum Institute of India (SII) to support the development and manufacturing of a Japanese…
[News Brief] Formosa Pharmaceuticals and SERI Partner for Ophthalmic Research
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have announced a research collaboration to develop ophthalmic formulations for corneal and ocular surface diseases, combining proprietary drug delivery technology with…
[News Brief] Formosa Pharmaceuticals and Singapore Eye Research Institute Partner on Ophthalmic Formulations
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have entered a research collaboration to develop ophthalmic formulations for corneal and ocular surface diseases. This summary is based on a…
[News Brief] International Vaccine Institute and Hilleman Laboratories Form Vaccine Development Partnership
The International Vaccine Institute (IVI) and Hilleman Laboratories have entered a strategic partnership to collaborate on the development of vaccines and biologics addressing global public health needs. This summary is…
[News Brief] Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals
Everest Medicines has entered a share purchase agreement to acquire Hasten Biopharmaceuticals (SG) Pte. Ltd., aiming to expand its commercial presence in the Asia Pacific region and strengthen its chronic…
[News Brief] UBT251 Phase 2 Trial Shows HbA1c Reduction in Chinese Patients with Type 2 Diabetes
United Biotechnology and Novo Nordisk have reported topline results from a phase 2 trial of UBT251 in Chinese patients with type 2 diabetes, demonstrating reductions in HbA1c and body weight…
[News Brief] Next Generation Sequencing Gains Traction in APAC Biologics
PathoQuest highlighted the growing adoption of next generation sequencing (NGS) in Asia-Pacific biologics development, supporting viral safety, contamination detection, and regulatory alignment during the APAC Biomanufacturing Leadership Summit 2026. This…
[News Brief] Galderma Expands Restylane Portfolio with Two New Launches in Japan
Galderma has launched Restylane Defyne and Restylane Refyne, the first Optimal Balance Technology (OBT)–based hyaluronic acid injectables authorised in Japan. This summary is based on a report from BioSpectrum Asia…
[News Brief] Japan Approves Clinigen’s Therapeutic Human Milk Fortifier for VLBW Infants
Japan’s Ministry of Health, Labour and Welfare has approved a human milk-based fortifier for very low birth weight (VLBW) infants, marking a world-first approval for this type of product. This…
[News Brief] Kwangdong Pharmaceutical Enters Singapore Market with Vita500 Vitamins
South Korean healthcare company Kwangdong Pharmaceutical has entered the Singapore market with its Vita500 range of vitamin products, marking an expansion of its operations beyond South Korea. The Vita500 range…
[News Brief] Meiji Seika Pharma to Set Up Singapore Subsidiary for ASEAN Expansion
Meiji Seika Pharma Co., Ltd. plans to establish a local subsidiary in Singapore in spring 2026 to strengthen its commercial operations in the ASEAN region, with a focus on pharmaceuticals…
[News Brief] Sun Pharma Receives Indian Approval for Liraglutide
Sun Pharmaceutical Industries has received approval from the Drug Controller General of India (DCGI) to manufacture a generic version of semaglutide, a GLP-1 receptor agonist used for weight management and…
[News Brief] Akeso’s Ivonescimab Named Key Drug for 2026
Akeso’s bispecific antibody ivonescimab has been included in FirstWord Pharma’s “Spotlight On: The Drugs That Will Shape 2026” list of key drugs poised to influence the global pharmaceutical landscape. This…
[News Brief] China Approves Enhertu for Second-Line Gastric Cancer
China’s authorities have approved Enhertu (trastuzumab deruxtecan) as the first HER2-directed antibody-drug conjugate for patients with HER2-positive metastatic gastric cancer. This summary is based on a press release issued by…
[News Brief] Daiichi Sankyo Appoints New European Research Leadership
Daiichi Sankyo has announced a leadership transition at its Translational Research Centre Europe, with Veronika Müller succeeding Jürgen Müller. This summary is based on a press release issued by Daiichi…
[News Brief] Kowa Launches Ripasudil Combination Therapy in Singapore
Kowa Co., Ltd has announced the launch in Singapore of GLA-ALPHA® Combination Ophthalmic Solution, a new fixed-dose eye drop licensed from D. Western Therapeutics Institute (DWTI) for the treatment of…
[News Brief] Asia Summit on Global Health 2026 Set for Hong Kong
The Asia Summit on Global Health (ASGH) 2026 will be held at the Hong Kong Convention and Exhibition Centre from 11–12 May 2026. This summary is based on an announcement…
[News Brief] Chinese Medicines Increasingly Reach Global Health Market
A report from China’s State Council Information Office shows that Chinese-made medicines and medical devices are gaining a stronger foothold in global health markets. This summary is based on an…
[News Brief] C&R Research Strengthens Clinical Trial Capabilities in Indonesia
C&R Research, a South Korean contract research organisation (CRO), is expanding its clinical trial operations in Indonesia as part of its broader ASEAN growth strategy. This summary is based on…
[News Brief] Kerry Releases 2026 Supplement Taste Charts
Kerry has published its 2026 Taste Charts, identifying emerging flavour trends for the supplements and sports nutrition sectors. This summary is based on a press release issued by Kerry.
![[News Brief] GSK Receives Japanese Approval for Depemokimab](https://www.ehub365.com/wp-content/uploads/2026/01/News-Brief-GSK-Receives-Japanese-Approval-for-Depemokimab.jpg)
[News Brief] GSK Receives Japanese Approval for Depemokimab
Japan’s Ministry of Health, Labour and Welfare has approved GSK’s depemokimab (Exdensur) as an add-on treatment for certain types of severe asthma. This summary is based on a press release…
[News Brief] Lunit and Daiichi Sankyo Partner for AI‑Driven Biomarker Discovery and Translational Oncology Research
Lunit has announced a collaboration with Daiichi Sankyo to advance research in AI‑driven biomarker discovery and translational oncology. This summary is based on a press release issued by Lunit.
[News Brief] Linaprazan Glurate Included in China’s National Reimbursement List
Cinclus Pharma Holding AB’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) ahead of its planned commercial launch. This summary is based on a…
[News Brief] Gushengtang Launches 10 AI Avatars of Renowned Traditional Chinese Medicine Practitioners
Gushengtang has introduced 10 AI avatars modelled on renowned Traditional Chinese Medicine (TCM) experts as part of its ongoing integration of artificial intelligence with TCM practice. This summary is based…
[News Brief] Circle DNA Launches Whole Exome Genetic Test with JD.com
Circle DNA, a joint venture between Berry Genomics and Prenetics, launched a consumer genetic test in China on April 22, 2019. The service utilises Whole Exome Sequencing (WES) to provide…